Amylyx Pharmaceuticals, Inc. (AMLX) › Total AssetsAmylyx Pharmaceuticals, Inc. (AMLX) — Total AssetsAnnual figures by period end, from SEC filings.2021-12-31: $105.61M2022-12-31: $391.45M2023-12-31: $517.45M2024-12-31: $193.63M2025-12-31: $332.64M$332.64M2021-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$332.64M+71.8%2026-03-03Balance as of period end2024-12-31$193.63M-62.6%2026-03-03Balance as of period end2023-12-31$517.45M+32.2%2025-03-04Balance as of period end2022-12-31$391.45M+270.6%2024-02-22Balance as of period end2021-12-31$105.61M—2023-03-13Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)